Global Vascular Grafts Market

Introduction

The Global Vascular Grafts Market is experiencing continued growth, driven by the rising prevalence of vascular diseases, cardiovascular disorders, chronic kidney disease, aneurysms, and end-stage renal disease. Increasing surgical procedures, advancements in vascular graft materials, and growing adoption of minimally invasive vascular interventions are also supporting market expansion. Technological developments in synthetic, biological, and hybrid grafts are further focused on improving durability, biocompatibility, patency, and patient outcomes.

Get Free Sample Of This Premium Report

https://www.decisionsadvisors.com/request-sample/DAR4325

Vascular Grafts Market Insights

The Global Vascular Grafts Market was valued at approximately USD 3.45 Billion in 2024 and is projected to reach around USD 6.67 Billion by 2035.

From 2025 to 2035, the market is expected to grow at a CAGR of 6.18%. Key factors supporting growth include the increasing prevalence of peripheral artery disease, coronary artery disease, chronic kidney disease, aneurysms, and the rising number of vascular and cardiovascular procedures.

Based on Product, Endovascular Stent Grafts accounted for the largest share of the market in 2024 and are anticipated to grow at a significant CAGR during the forecast period. These grafts are widely used for conditions such as thoracic and abdominal aortic aneurysms and can provide minimally invasive treatment with reduced recovery time.

Based on Raw Material, Synthetic Vascular Grafts held the highest revenue share in 2024 and are expected to maintain significant growth. Polyester-based grafts are widely used because of their mechanical strength and suitability for vascular procedures.

Other Key Findings

• Asia-Pacific is anticipated to hold the largest share of the global vascular grafts market over the forecast period.
• Europe is projected to experience the fastest CAGR during the forecast period.
• Increasing healthcare infrastructure, an aging population, and the rising incidence of cardiovascular and renal diseases are supporting growth in Asia-Pacific.
• Technological advancements are driving the development of more durable, biocompatible, and patient-focused vascular graft solutions.
• Growing adoption of minimally invasive procedures is creating demand for advanced graft designs.
• High procedure costs, infection risks, graft failure, and stringent regulatory requirements remain important market challenges.

Report Summary

The report provides revenue forecasts at global, regional, and country levels and evaluates market trends, growth drivers, challenges, opportunities, and competitive developments.

Segmentation Covered

Regional Coverage

• North America: U.S., Canada, Mexico
• Europe: Germany, UK, France, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific
• South America: Brazil, Argentina, Rest of South America
• Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa

Report Coverage

The Global Vascular Grafts Market report provides comprehensive coverage of:

• Revenue forecasts and market sizing
• Product and raw material segmentation
• Regional and country-level analysis
• Market growth drivers
• Industry trends and opportunities
• Market restraints and challenges
• Technological developments
• Competitive landscape
• Company strategies
• Product launches and innovations
• Partnerships, mergers, and acquisitions
• Regulatory developments
• Strategic analysis of key market players

Companies

The key companies profiled in the Global Vascular Grafts Market include:

• Abbott
• B. Braun Melsungen AG
• BD (Becton Dickinson)
• Cook Medical
• Endologix
• Getinge AB
• LeMaitre Vascular, Inc.
• Medtronic
• MicroPort Scientific Corporation
• Shanghai Suokang Medical Implants Co. Limited
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Others

The report evaluates these companies based on product offerings, business overview, geographic presence, strategies, segment positioning, and competitive developments.

Recent Market Developments

• In March 2025, researchers at the University of Wisconsin–Madison and the Morgridge Institute for Research developed stem cell-based vascular grafts designed to provide off-the-shelf bioengineered arteries for potential use in cardiac surgery.
• In January 2025, Cornell University researchers developed a biodegradable vascular graft designed to mimic natural arteries and support treatment of smaller blood vessels.
• In December 2024, the U.S. FDA approved Symvess, an acellular tissue-engineered vessel for certain vascular trauma cases where urgent revascularization is required and an autologous vein graft is not feasible.

Want detailed insights, forecasts, and competitive analysis?

Check out the full Global Vascular Grafts Market report:

https://www.decisionsadvisors.com/reports/vascular-grafts-market